Ahmed Md Sabbir, Bartram Mary, Gabrys Robert, Mela Mansfield, Muhajarine Nazeem
Saskatchewan Population Health and Evaluation Research Unit, University of Saskatchewan, 104 Clinic Place, Saskatoon, SK S7N 2Z4, Canada.
Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Int J Environ Res Public Health. 2024 Dec 10;21(12):1644. doi: 10.3390/ijerph21121644.
This study was aimed at identifying the prevalence of concurrent experience, poor mental health and problematic substance use, and its associated factors, among Canadian adults during the COVID-19 pandemic. A nationwide repeated cross-sectional sample of 14,897 Canadian adults (quota-sampled, weighted) were recruited on ten occasions between October 2020 and March 2022 using online panels. Concurrent experience was defined as mild to severe symptoms of depression (Patient Health Questionnaire-9) and/or anxiety (Generalized Anxiety Disorder-7) AND meeting screening criteria for problematic cannabis (Cannabis Use Disorder Identification Test-Revised) and/or problematic alcohol use (Alcohol Use Disorder Identification Test). Multivariable binary logistic regression models were fitted to identify the associated factors of concurrent experience using Stata v14.2 SE software. The pooled prevalence of concurrent experience was 17.12%, and 45.54% of the participants reported at least one experience (mental health symptoms or problematic substance use). The highest prevalence of concurrent experience per province was reported in Saskatchewan (19.4%) and the lowest in Quebec (13.6%). Younger adults, male respondents, those identifying as 2SLGBTQ+, self-reporting ethnocultural minority status, diagnostic history of mental health and substance use disorder, suicidal ideation, and lower ability to handle unexpected/difficult situations were significantly associated with concurrent experience during the COVID-19 pandemic in Canada. This analysis showed that the COVID-19 pandemic significantly impacted mental health and substance use in interrelated ways. Data-driven province-specific interventions might be helpful toward a client-centered and integrated mental health and substance use care system in Canada.
本研究旨在确定在新冠疫情期间加拿大成年人中并发经历、心理健康不佳和物质使用问题的流行情况及其相关因素。2020年10月至2022年3月期间，通过在线面板对14897名加拿大成年人（配额抽样、加权）进行了十次全国性重复横断面抽样。并发经历被定义为有轻度至重度抑郁症状（患者健康问卷-9）和/或焦虑症状（广泛性焦虑障碍-7），且符合大麻使用问题（修订版大麻使用障碍识别测试）和/或酒精使用问题（酒精使用障碍识别测试）的筛查标准。使用Stata v14.2 SE软件拟合多变量二元逻辑回归模型，以确定并发经历的相关因素。并发经历的合并患病率为17.12%，45.54%的参与者报告至少有一种经历（心理健康症状或物质使用问题）。并发经历患病率最高的省份是萨斯喀彻温省（19.4%），最低的是魁北克省（13.6%）。在加拿大新冠疫情期间，年轻人、男性受访者、自我认同为2SLGBTQ+的人、自我报告为少数族裔文化身份的人、有心理健康和物质使用障碍诊断史的人、有自杀意念的人，以及处理意外/困难情况能力较低的人，与并发经历显著相关。该分析表明，新冠疫情以相互关联的方式对心理健康和物质使用产生了重大影响。以数据为驱动的针对特定省份的干预措施可能有助于在加拿大建立以客户为中心的综合心理健康和物质使用护理系统。
